Blog Grid

VERTIS CV Trial- Safety of SGLT2 inhibitor ertugliflozin in patients with (T2D) and established atherosclerotic cardiovascular disease

SURMOUNT-OSA Trial- Evaluating the effects of GLP-1 receptor agonists (GLP-1RAs) on obstructive sleep apnea (OSA)

GLP-1RAs/SGLT2 and Cardiovascular Risk in Patients with OSA 

OSA in Acute Coronary Syndrome patients

Idiopathic Hypersomnia Clinical presentation and management

Wisconsin Sleep Cohort study- Methodology and main findings

Comparative table summarizing the Sleep Heart Health Study (SHHS), Multi-Ethnic Study of